In vitro metabolism of deoxycoformycin in human T lymphoblastoid cells. Phosphorylation of deoxycoformycin and incorporation into cellular DNA.

This publication has 19 references indexed in Scilit:

• Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin.
  Proceedings of the National Academy of Sciences, 1984
• Phenotypic conversion of acute leukaemia from T‐lymphoblastic to myeloblastic induced by therapy with 2′‐deoxycoformycin
  British Journal of Haematology, 1983
• Biochemical and Functional Abnormalities in Lymphocytes from an Adenosine Deaminase-deficient Patient during Enzyme Replacement Therapy
  Journal of Clinical Investigation, 1981
• Adenosine deaminase and adenylate deaminase: comparative kinetic studies with transition state and ground state analog inhibitors
  Biochemistry, 1980
• ATP depletion as a consequence of adenosine deaminase inhibition in man.
  Proceedings of the National Academy of Sciences, 1980
• Purinogenic Immunodeficiency Diseases
  Journal of Clinical Investigation, 1979
• The metabolism of 2'-deoxycoformycin by L1210 cells invitro
  Biochemical Pharmacology, 1979
• Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.
  Proceedings of the National Academy of Sciences, 1978
• ISOLATION AND PROPERTIES OF A VIDARABINE DEAMINASE INHIBITOR, CO‐VIDARABINE
  Annals of the New York Academy of Sciences, 1977
• Deoxynucleotide-Polymerizing Enzymes of Calf Thymus Gland, IV. Inhibition of Terminal Deoxynucleotidyl Transferase by Metal Ligands
  Proceedings of the National Academy of Sciences, 1970